A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients
Clinical trial NCT06115993 · COMPLETED
Trial details
- NCT number
- NCT06115993
- Sponsor
- Ausper Biopharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-03
- Primary completion
- 2024-12-03
- Enrollment
- 129
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.